Compared to the pharmaceutical market, the vaccine market is relatively small and concentrated on both supply and demand sides. It is highly regulated and largely dependent on public purchasers and donor policies. The vaccine market has very distinct features, which increase the complexity of assessing and understanding pricing and procurement. It is made up of individual markets for individual vaccines or vaccine types, each with their own specificities, particularly on the supply side.
This page describes the dynamics of individual vaccine markets and addresses both market divergence and convergence.
This page provides an introduction to research based and emerging vaccine manufacturers and describes monopolistic and oligopolistic vaccine markets.
This page introduces the main actors on the demand side of the vaccine market: high, middle and low income countries, pooled procurement agencies and the private sector.